US Patent 11913039 Method for producing recombinant alkaline phosphatase
Patent 11913039 was granted and assigned to Alexion Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+64 properties)
Article (+242 characters)
US Patent 11913039 Method for producing recombinant alkaline phosphatase
Article
Patent abstract
A method of producing recombinant alkaline phosphatase comprising control of production parameters, particularly harvest clarified culture fluid (HCCF) and filtration pool (UFDF), to provide a defined total sialic acid content.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Meghan Dewitt0
Rahul Godawat0
Saravanamoorthy Rajendran0
Siguang Sui0
Date of Patent
February 27, 2024
0Patent Application Number
170434640
Date Filed
March 13, 2019
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 11913039 Method for producing recombinant alkaline phosphatase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
